Oncology
-
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy
This article has 59 authors:Reviewed by ScreenIT
-
Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer
This article has 46 authors:Reviewed by ScreenIT
-
Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients
This article has 22 authors:Reviewed by ScreenIT
-
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer
This article has 18 authors:Reviewed by ScreenIT
-
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
This article has 14 authors:Reviewed by ScreenIT
-
Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling
This article has 21 authors:This article has been curated by 1 group:Reviewed by eLife
-
Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States
This article has 24 authors:Reviewed by ScreenIT
-
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination
This article has 20 authors:Reviewed by ScreenIT
-
COVID ‐19 outcomes in patients with cancer: Findings from the University of California health system database
This article has 9 authors:Reviewed by ScreenIT
-
Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy
This article has 10 authors:Reviewed by ScreenIT